东莞市汉维科技股份有限公司 证券代码：836957 证券简称：汉维科技 公告编号：2023-062 二、《关于公司募投项目延期的议案》的独立意见 本次募投项目延期是公司根据项目实施的实际情况做出的审慎决定，不属于 募投项目实质性变更及变相改变募集资金用途的情形，不存在损害公司及全体股 东利益的情形，不会对公司生产经营造成重大不利影响。本次募投项目延期事项 履行了必要的审批及决策程序，符合相关法律法规、规范性文件的有关规定。 因此，我们一致同意上述议案。 独立董事关于第三届董事会第十七次会议相关议案的独立意见公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 东莞市汉维科技股份有限公司（以下简称"公司"）于 2023 年 8 月 29 日召 开了第三届董事会第十七次会议，根据《东莞市汉维科技股份有限公司章程》《东 莞市汉维科技股份有限公司独立董事工作制度》的有关规定，作为公司独立董事， 本着谨慎原则及独立判断的立场，经对公司提交的相关资料、决策程序等进行核 查，我们对第三届董事会第十七次会议审议的相关议 ...

证券代码：836957 证券简称：汉维科技 公告编号：2023-060 关于召开 2023 年第三次临时股东大会通知公告（提供网络投票） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开基本情况 （一）股东大会届次 本次会议为 2023 年第三次临时股东大会。 （二）召集人 本次股东大会的召集人为董事会。 （三）会议召开的合法性、合规性 东莞市汉维科技股份有限公司 本次股东大会的召集及召开时间、方式、召集人及主持人符合《中华人民共 和国公司法》《东莞市汉维科技股份有限公司章程》及《股东大会议事规则》等 有关规定。 （四）会议召开方式 本次会议采用现场投票和网络投票相结合方式召开。 公司股东应选择现场投票和网络投票表决方式的一种方式，如果同一表决 权出现重复投票表决的，以第一次投票表决结果为准。 （五）会议召开日期和时间 1、现场会议召开时间：2023 年 9 月 25 日 14:50。 2、网络投票起止时间：2023 年 9 月 24 日 15:00—2023 年 9 月 25 日 15:0 ...

东莞证券股份有限公司 关于东莞市汉维科技股份有限公司 募投项目延期的核查意见 东莞证券股份有限公司（以下简称"东莞证券"或"保荐机构"）作为东莞 市汉维科技股份有限公司（以下简称"汉维科技"或"公司"）向不特定合格投 资者公开发行股票的保荐机构，根据《北京证券交易所股票上市规则（试行）》 《北京证券交易所上市公司持续监管办法（试行）》《北京证券交易所证券发行上 市保荐业务管理细则》《上市公司监管指引第 2 号——上市公司募集资金管理和 使用的监管要求》等相关规定，对公司募投项目延期事项进行了审慎核查，具体 情况如下： 一、募集资金基本情况 汉维科技于 2022 年 11 月 16 日收到中国证券监督管理委员会下发的《关于 同意东莞市汉维科技股份有限公司向不特定合格投资者公开发行股票注册的批 复》（证监许可〔2022〕2861 号），同意公司向不特定合格投资者公开发行股票 的注册申请。 公司本次发行的发行价格为 6.50 元/股，实际发行股数为 1,557.2134 万股（未 行使超额配售选择权），实际募集资金总额为 101,218,871.00 元，扣除保荐承销 费用 8,956,280.29 元后的余额为 ...

1.会议召开时间：2023 年 8 月 29 日 2.会议召开地点：东莞市汉维科技股份有限公司会议室 证券代码：836957 证券简称：汉维科技 公告编号：2023-058 东莞市汉维科技股份有限公司 第三届董事会第十七次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 3.会议召开方式：现场及视频方式 4.发出董事会会议通知的时间和方式：2023 年 8 月 18 日以书面或电子通讯 方式发出 5.会议主持人：周述辉先生 6.会议列席人员：监事及高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议从会议召集、召开、议案审议程序等方面符合《公司法》等法律、 法规、规范性文件以及《公司章程》的规定。 （二）会议出席情况 会议应出席董事 9 人，出席和授权出席董事 9 人。 二、议案审议情况 （一）审议通过《关于公司 2023 年半年度报告及其摘要的议案》 1.议案内容： 根据《中华人民共和国公司法》及《东莞市汉维科技股份有限公司章程》等 相 ...

第三届监事会第十二次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 证券代码：836957 证券简称：汉维科技 公告编号：2023-059 东莞市汉维科技股份有限公司 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2023 年 8 月 29 日 2.会议召开地点：东莞市汉维科技股份有限公司会议室 3.会议召开方式：现场及视频方式 4.发出监事会会议通知的时间和方式：2023 年 8 月 18 日 以书面或电子通讯方式 发出 5.会议主持人：陈君林先生 6.召开情况合法、合规、合章程性说明： 本次会议从会议召集、召开、议案审议程序等方面符合《公司法》等法律、 法规、规范性文件以及《公司章程》的规定。 （二）会议出席情况 会议应出席监事 3 人，出席和授权出席监事 3 人。 二、议案审议情况 （一）审议通过《关于公司 2023 年半年度报告及其摘要的议案》议案 1.议案内容： 根据《中华人民共和国公司法》及《东莞市汉维科技股份有限公司章程》等 相关规定，公司将在北京证券交易所信 ...

Company Recognition and Achievements - The company achieved a significant milestone by being recognized as a "Key Laboratory for Polymer Material Additives" in Dongguan[7]. - The company's product, zinc stearate, was awarded the title of "Single Champion Product" in Dongguan[8]. - The company is recognized as a national-level "specialized, refined, distinctive, and innovative" enterprise, contributing to its competitive edge in the fine chemical industry[36]. Financial Performance - The company reported a revenue of CNY 211.30 million, a decrease of 19.31% compared to the same period last year[27]. - The net profit attributable to shareholders was CNY 9.53 million, down 58.90% year-over-year[27]. - The net cash flow from operating activities was CNY 14.05 million, a decline of 63.56% from the previous year[29]. - Total assets decreased by 3.12% to CNY 566.31 million, while total liabilities increased by 3.23% to CNY 187.48 million[31]. - Operating revenue decreased by 19.31% to CNY 211,301,457.97, while operating costs decreased by 18.86% to CNY 179,623,651.15, resulting in a gross margin of 14.99%[43]. - Net profit fell by 64.99% to CNY 8,065,819.44, largely due to a significant decline in raw material prices affecting sales prices[44]. - Management expenses rose by 41.76% due to increased depreciation and amortization from the transfer of the Indonesian factory to fixed assets[45]. - Financial expenses surged by 395.72% primarily due to increased interest expenses from lease liabilities and foreign exchange losses[45]. - Investment income increased by 34.36% due to higher returns from low-risk financial products purchased in 2023[46]. - The company experienced a significant decrease in total profit, which was ¥9,190,103.44, down from ¥26,025,056.90 in the previous year[108]. Shareholder Information - The total share capital of the company is 107,301,334 shares[23]. - The company reported a total of 107,301,334 shares outstanding, with 25.00% being unrestricted shares and 75.00% being restricted shares[78]. - The company’s major shareholders include Zhou Shuhui with 32.32% and Tan Zhijia with 14.36% of the shares[80]. - The total number of shares held by the top five shareholders is 75,996,000, accounting for 70.82% of the total shares[90]. Market and Product Development - The company is actively expanding its market for stearate products, with increased sales volume compared to the previous year[37]. - The company aims to enhance its market presence by expanding into international markets and broadening its sales channels[66]. - The company plans to increase production capacity by 60,000 tons of fatty acid salt additives, 25,000 tons of fatty acid esters, 25,000 tons of fatty amides, and 10,000 tons of special additives through its fundraising projects[68]. Investments and Projects - The company is making substantial progress with its Indonesian subsidiary project, which is expected to enhance international competitiveness and profitability[37]. - The company has entered the main construction and decoration phase for its fundraising project, which will diversify its product structure and enhance risk resistance[37]. - The company has invested 42,913,500 yuan in the construction of an annual production project for 120,000 tons of environmental additives, with a remaining balance of 46,954,000 yuan from the raised funds[84]. Cash Flow and Liquidity - Cash and cash equivalents decreased by 45.44% due to the company's investment in bank wealth management products and cash dividends paid[42]. - Cash flow from operating activities decreased by 63.56% to CNY 14,045,117.09, attributed to a decline in sales collections[54]. - The company paid cash dividends of CNY 32,190,400 in 2023, contributing to a significant drop in cash flow from financing activities[55]. - The net increase in cash and cash equivalents for the first half of 2023 was -¥91,279,588.75, contrasting with a net increase of ¥45,429,058.96 in the first half of 2022[116]. Employee and Corporate Governance - The company has a total of 186 employees as of the end of the reporting period, an increase of 22 employees from the beginning of the period[95]. - The company is committed to improving employee welfare by providing good working conditions and social insurance[63]. - The total number of directors is 9, and the total number of supervisors is 3[90]. - The company appointed a new supervisor, Zhang Shuhong, during the reporting period[92]. Regulatory and Compliance - The company has not faced any delisting risks as per the latest report[14]. - The company has not undergone any changes in registration during the reporting period[24]. - The company has not disclosed any voluntary information during the reporting period[25]. - The company has not faced any investigations or penalties during the reporting period[72]. - There are no related party transactions or external guarantees reported by the company[71]. Assets and Liabilities - The total amount of assets pledged or mortgaged by the company is 57,158,601.48 yuan, accounting for 10.10% of total assets[75]. - The company's current assets as of June 30, 2023, amount to ¥381,025,602.59, a decrease from ¥420,010,956.61 at the end of 2022[99]. - The company's cash and cash equivalents are reported at ¥120,116,605.33 as of June 30, 2023, down from ¥220,156,949.93 at the end of 2022[99]. - The total accounts receivable at the end of the period is $61,808,038.23, compared to $61,935,612.79 at the end of the previous year, reflecting a decrease of approximately 0.2%[143]. Research and Development - The company maintains a strong focus on R&D, having obtained multiple patents and implemented advanced automated production lines[33]. - Research and development expenses remained stable at ¥7,969,845.08, slightly up from ¥7,929,626.76 year-over-year[108].

Financial Performance - Operating revenue for Q1 2023 was CNY 95,926,709.73, down 21.81% year-over-year from CNY 122,686,036.38[10] - Net profit attributable to shareholders for Q1 2023 was CNY 4,928,870.08, a decline of 54.12% compared to CNY 10,742,708.31 in the same period last year[10] - Basic earnings per share decreased by 58.33% to CNY 0.05 from CNY 0.12[11] - Total operating costs for Q1 2023 were ¥92,089,131.20, down 17.1% from ¥110,989,232.01 in Q1 2022[38] - Net profit for Q1 2023 was ¥4,387,054.94, representing a decline of 58.9% from ¥10,687,963.17 in Q1 2022[39] - Basic and diluted earnings per share were both 0.06 yuan, compared to 0.11 yuan in the same period last year, representing a decrease of 45.45%[43] Cash Flow - The company's cash flow from operating activities fell by 70.24% to CNY 3,963,672.86, primarily due to reduced cash inflow from operations[12] - Net cash flow from operating activities was 3,963,672.86 yuan, a significant decline of 70.24% from 13,317,782.90 yuan in the previous year[46] - Cash inflow from operating activities totaled 83,428,130.97 yuan, down 34.06% from 126,531,404.21 yuan year-over-year[44] - Cash outflow from operating activities was 79,464,458.11 yuan, a decrease of 29.78% compared to 113,213,621.31 yuan in the same period last year[44] - Net cash flow from investment activities was -92,660,223.62 yuan, compared to a positive cash flow of 8,438,239.56 yuan in the previous year[46] - Cash inflow from investment activities was 30,160,270.77 yuan, down 74.60% from 118,591,931.41 yuan year-over-year[46] - Cash outflow from investment activities increased to 122,820,494.39 yuan, up 11.54% from 110,153,691.85 yuan in the previous year[46] - The ending cash and cash equivalents balance was 105,433,393.29 yuan, compared to 78,923,703.50 yuan at the end of the same period last year, reflecting an increase of 33.67%[46] - The company reported a net decrease in cash and cash equivalents of -89,245,378.30 yuan, contrasting with an increase of 22,424,006.67 yuan in the previous year[46] Assets and Liabilities - Total assets as of March 31, 2023, were CNY 580,332,764.51, a decrease of 0.72% compared to the end of 2022[10] - Total current assets decreased to CNY 400,795,848.41 from CNY 420,010,956.61, a decline of approximately 4.3%[29] - Cash and cash equivalents decreased to CNY 122,755,818.65 from CNY 220,156,949.93, a drop of about 44.3%[29] - Total non-current assets increased to CNY 179,536,916.10 from CNY 164,559,019.68, an increase of approximately 9.1%[30] - Total liabilities decreased to CNY 173,716,977.62 from CNY 181,612,127.38, a reduction of about 4.8%[31] - Total equity attributable to shareholders increased to CNY 401,181,783.94 from CNY 396,982,030.82, an increase of approximately 1.1%[31] - Total liabilities decreased to ¥137,373,855.33 in Q1 2023 from ¥145,947,416.84 in Q1 2022, a reduction of 5.9%[35] - Total equity increased to ¥404,988,228.44 in Q1 2023 from ¥398,954,602.18 in Q1 2022, an increase of 1.5%[35] Shareholder Information - The company reported a total of 92,047,198 shares held by the top ten shareholders, representing 85.78% of total shares[19] - The largest shareholder, Zhou Shuhui, holds 34,676,200 shares, accounting for 32.32% of total shares[19] Expenses - Management expenses increased by 38.44%, mainly due to the commencement of depreciation for the Indonesian facility starting January 2023[12] - Financial expenses rose by CNY 1,320,500, primarily due to increased interest expenses from land leasing and loans in Indonesia[12] - Research and development expenses for Q1 2023 were ¥3,733,679.30, slightly down from ¥3,868,272.49 in Q1 2022[38] - Financial expenses for Q1 2023 were ¥1,128,468.83, compared to a financial income of ¥192,079.74 in Q1 2022[38] Other Information - There are no ongoing litigation or arbitration matters reported during the period[22] - The company has not engaged in any external guarantees or loans during the reporting period[22] - The company has disclosed that there are no significant changes in previously reported commitments[24] - The company has a bank credit limit of up to 100 million RMB approved by the board of directors[23] - The company has pledged assets totaling 59,324,072.68 RMB, which constitutes 10.21% of total assets[25] - The company has a total of 17,322,425.36 RMB in cash pledged as collateral, representing 2.98% of total assets[25] - The company’s fixed assets, including real estate, are valued at 10,944,045.32 RMB and are mortgaged for bank credit[25] - The company executed daily related transactions in compliance with internal procedures[22] - The company reported a credit impairment loss of ¥929,659.95 in Q1 2023, compared to a gain of ¥33,450.85 in Q1 2022[38] - Total comprehensive income for the period was 6,033,626.26 yuan, down from 10,485,786.80 yuan year-over-year[43] - The company is focusing on expanding its trading financial assets, which saw a significant increase, indicating a strategic shift towards investment opportunities[29]

证券代码：836957 证券简称：汉维科技 公告编号：2023-047 东莞市汉维科技股份有限公司 2022 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、 说明会类型 东莞市汉维科技股份有限公司（以下简称"公司"）于 2023 年 3 月 29 日在 北京证券交易所信息披露平台（www.bse.cn）披露了《2022 年年度报告》（公告 编号：2023-027）及《2022 年年度报告摘要》（公告编号：2023-032），为方便广 大投资者更深入了解公司 2022 年年度经营业绩的具体情况，加强与投资者的互 动交流，公司拟召开 2022 年年度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2023年4月14日（星期五）15:00-17:00 。 （二）会议召开地点 本次年度报告业绩说明会将采用网络方式召开，投资者可登陆全景网"投 资者关系互动平台"（http://ir.p5w.net）参与本次业绩说明会。 三、 参加人员 公司董事长、总经理：周 ...

Financial Performance - The company's operating revenue for 2022 was CNY 487.88 million, a decrease of 7.20% compared to CNY 525.74 million in 2021[29]. - The net profit attributable to shareholders for 2022 was CNY 35.87 million, an increase of 8.87% from CNY 32.94 million in 2021[29]. - The total assets increased by 17.16% to CNY 584.57 million in 2022, up from CNY 498.96 million in 2021[31]. - The total liabilities decreased by 17.03% to CNY 181.61 million in 2022, down from CNY 218.88 million in 2021[31]. - The company's gross profit margin improved to 14.65% in 2022, compared to 13.47% in 2021[29]. - The cash flow from operating activities for 2022 was CNY 63.80 million, a significant increase of 552.21% from a negative CNY 14.11 million in 2021[33]. - The weighted average return on equity based on net profit attributable to shareholders was 12.30% in 2022, down from 12.81% in 2021[29]. - The company reported a basic earnings per share of CNY 0.39 in 2022, an increase of 8.33% from CNY 0.36 in 2021[29]. - The company experienced a net profit growth rate of 7.82% in 2022, compared to a decline of 23.61% in 2021[34]. - The company achieved a total non-recurring profit and loss of 3,346,079.41 in 2022, compared to 4,085,289.64 in 2021, indicating a decline of approximately 18.1%[40]. Production and Capacity Expansion - The company plans to add 60,000 tons of fatty acid salt additives, 25,000 tons of fatty acid esters, 25,000 tons of fatty acid amides, and 10,000 tons of special additives upon completion of its fundraising projects[13]. - The company commenced construction of its environmental additives production project on March 5, 2022[4]. - The company has completed the construction of its environmental additive production project, which began on March 5, 2022[49]. - The company expects continued growth in the PE wood-plastic production capacity, with an annual compound growth rate of 10%-20% projected until 2025[57]. - The company will prioritize market expansion efforts to ensure the timely absorption of new production capacity from fundraising projects[128]. Research and Development - The company holds a total of 30 patents, including 10 invention patents, an increase from 29 patents in the previous period[93]. - The company is in the trial production stage for several R&D projects, including a low-foam grinding aid for UV wood coatings, which aims to address existing processing issues[94]. - A new water-based zinc stearate emulsion is being developed, expected to enhance product performance and support industry upgrades[95]. - The company is working on a low-acid magnesium stearate project aimed at improving competitiveness in the pharmaceutical-grade market[96]. - The development of a high-solid content calcium stearate lubricant is underway, which is anticipated to yield two new products and improve market competitiveness[96]. - The company has initiated projects to produce high-performance PVC wallboard materials and organic auxiliary heat stabilizers, aligning with sustainable development strategies[96]. Risk Management - The company faces risks related to the inability to fully pass on raw material price increases to downstream customers[12]. - The company’s operating performance is subject to significant fluctuations due to raw material price volatility[12]. - The company has identified a new risk regarding the absorption of additional production capacity from fundraising projects[13]. - The company faces risks from raw material price fluctuations, particularly for stearic acid, which is influenced by palm oil prices[117]. - The company has established a strategic cooperation model with stable suppliers to mitigate the impact of raw material price volatility[118]. Corporate Governance and Compliance - The company has committed to fulfilling its corporate social responsibility by adhering to laws, protecting the environment, and providing employment opportunities[110]. - The company has no significant impact on its financial status or operating results from the recent accounting policy changes[105][106]. - The company has completed the deregistration of Dongguan Han Innovation Materials Technology Co., Ltd. as of October 21, 2022[109]. - The company emphasizes the importance of risk management and aims to enhance its resilience through the implementation of investment projects[113]. - The company has not reported any unprofitable situations or cumulative losses during the reporting period[111]. Stock and Shareholder Management - The company's stock was listed on the Beijing Stock Exchange on December 14, 2022[5]. - The company is currently fulfilling commitments related to stabilizing stock prices after its listing, which includes measures to address stock price dips below net asset value[135]. - The company has committed to strict adherence to profit distribution regulations as per its articles of association and relevant laws[134]. - The company will enhance the management of raised funds to ensure their safe and effective use, thereby protecting the interests of investors, especially small and medium-sized investors[154]. - The company will accept social supervision and implement strict measures to ensure the fulfillment of commitments, including timely public explanations for any failures[160]. Financial Strategy and Investment - The company plans to use up to CNY 87 million of idle raised funds for cash management to enhance efficiency[25]. - The company will increase investment in product research and development to accelerate the conversion of R&D results and enhance sales scale and profitability[156]. - A cost management strategy will be implemented to control expenses and improve profit margins, with specific optimization tasks assigned to various departments[156]. - The company commits to fulfilling measures to compensate for any dilution of immediate returns, and if not fulfilled, will publicly explain the reasons and apologize to shareholders[159].

Financial Performance - The company's operating revenue for 2022 was ¥487,880,357.88, a decrease of 7.20% compared to the previous year[4]. - Net profit attributable to shareholders increased by 9.06% to ¥35,929,801.88, while net profit excluding non-recurring gains and losses rose by 12.20% to ¥33,065,672.40[5]. - Basic earnings per share increased by 8.33% to ¥0.39[5]. Assets and Equity - Total assets at the end of the reporting period reached ¥585,076,114.18, reflecting a year-on-year growth of 17.26%[6]. - Shareholders' equity attributable to the company increased by 45.10% to ¥397,044,846.64, primarily due to funds raised from issuing shares to unspecified qualified investors[6]. - The company's net asset value per share rose by 24.16% to ¥3.70[5]. Profitability Factors - The increase in net profit was attributed to enhanced price transmission capability, timing of raw material procurement, and proactive adjustment of customer structure[6]. Development Strategy - The company emphasized a pragmatic and steady development approach amid external macroeconomic uncertainties and the pandemic[5]. Financial Reporting - The financial data presented is preliminary and has not been audited, cautioning investors about potential risks[7]. - The final data will be disclosed in the company's official 2022 annual report[7].